Comparing two ways to estimate ovarian cancer risk
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study compares a new tool that estimates your personal risk of ovarian cancer with the usual approach. It aims to see if using this tool helps people make more informed decisions about screening and prevention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were assigned female at birth, including trans men and non-binary people with female reproductive organs.
- You are between 18 and 75 years old.
- You have a family history that may increase your risk of ovarian, fallopian tube, or peritoneal cancer, or you have a family member with a known cancer-related genetic variant.
- You are able to give informed consent.
- You can stay in the study area for the follow-up period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing new blood tests that might help detect ovarian cancer earlier by looking for specific markers. It involves people with suspected ovarian cancer and healthy volunteers, and aims to improve how we diagnose the disease.
This study looks at how well a blood test called CA-125, along with other markers and checkups, can detect ovarian cancer early. It’s for women considered low risk who will do regular blood tests and possibly a vaginal ultrasound if results suggest it.
This study tests whether a transvaginal ultrasound can be used as a screening tool for ovarian cancer in women at higher risk. It may help find ovarian cancer earlier in people who have a strong family or personal cancer history.
This study follows women who carry gene mutations that increase ovarian cancer risk to understand how preventive surgery affects their health, quality of life, and peace of mind. Researchers will track your outcomes over 3 years to help inform future treatment decisions for others at similar risk.
This study collects tissue samples and medical information from people at higher risk for ovarian cancer or undergoing gynecologic surgery. Researchers use this data to develop better ways to detect and prevent ovarian cancer early.
This study looks at whether a score based on your genes can predict the risk of epithelial ovarian cancer. It compares women newly diagnosed with this cancer to women who have never had it.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.